BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

681 related articles for article (PubMed ID: 28606182)

  • 21. Amyloid cored plaques in Tg2576 transgenic mice are characterized by giant plaques, slightly activated microglia, and the lack of paired helical filament-typed, dystrophic neurites.
    Sasaki A; Shoji M; Harigaya Y; Kawarabayashi T; Ikeda M; Naito M; Matsubara E; Abe K; Nakazato Y
    Virchows Arch; 2002 Oct; 441(4):358-67. PubMed ID: 12404061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early-life stress lastingly alters the neuroinflammatory response to amyloid pathology in an Alzheimer's disease mouse model.
    Hoeijmakers L; Ruigrok SR; Amelianchik A; Ivan D; van Dam AM; Lucassen PJ; Korosi A
    Brain Behav Immun; 2017 Jul; 63():160-175. PubMed ID: 28027926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EGb761 improves cognitive function and regulates inflammatory responses in the APP/PS1 mouse.
    Wan W; Zhang C; Danielsen M; Li Q; Chen W; Chan Y; Li Y
    Exp Gerontol; 2016 Aug; 81():92-100. PubMed ID: 27220811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative study of dietary curcumin, nanocurcumin, and other classical amyloid-binding dyes for labeling and imaging of amyloid plaques in brain tissue of 5×-familial Alzheimer's disease mice.
    Maiti P; Hall TC; Paladugu L; Kolli N; Learman C; Rossignol J; Dunbar GL
    Histochem Cell Biol; 2016 Nov; 146(5):609-625. PubMed ID: 27406082
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ApoE facilitates the microglial response to amyloid plaque pathology.
    Ulrich JD; Ulland TK; Mahan TE; Nyström S; Nilsson KP; Song WM; Zhou Y; Reinartz M; Choi S; Jiang H; Stewart FR; Anderson E; Wang Y; Colonna M; Holtzman DM
    J Exp Med; 2018 Apr; 215(4):1047-1058. PubMed ID: 29483128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of CRFR1 Ablation on Amyloid-β Production and Accumulation in a Mouse Model of Alzheimer's Disease.
    Campbell SN; Zhang C; Roe AD; Lee N; Lao KU; Monte L; Donohue MC; Rissman RA
    J Alzheimers Dis; 2015; 45(4):1175-84. PubMed ID: 25697705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heterozygous knockout of cytosolic phospholipase A
    Qu B; Gong Y; Gill JM; Kenney K; Diaz-Arrastia R
    Brain Res; 2017 Sep; 1670():248-252. PubMed ID: 28648388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of hepatic apoE does not influence early Aβ deposition: observations from a new APOE knock-in model.
    Huynh TV; Wang C; Tran AC; Tabor GT; Mahan TE; Francis CM; Finn MB; Spellman R; Manis M; Tanzi RE; Ulrich JD; Holtzman DM
    Mol Neurodegener; 2019 Oct; 14(1):37. PubMed ID: 31623648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic effects of glatiramer acetate and grafted CD115⁺ monocytes in a mouse model of Alzheimer's disease.
    Koronyo Y; Salumbides BC; Sheyn J; Pelissier L; Li S; Ljubimov V; Moyseyev M; Daley D; Fuchs DT; Pham M; Black KL; Rentsendorj A; Koronyo-Hamaoui M
    Brain; 2015 Aug; 138(Pt 8):2399-422. PubMed ID: 26049087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of IMPY as a potential imaging agent for beta-amyloid plaques in double transgenic PSAPP mice.
    Kung MP; Hou C; Zhuang ZP; Cross AJ; Maier DL; Kung HF
    Eur J Nucl Med Mol Imaging; 2004 Aug; 31(8):1136-45. PubMed ID: 15007564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of Cyclooxygenase-1 in Activated Microglia During Amyloid Plaque Progression: PET Studies in Alzheimer's Disease Model Mice.
    Shukuri M; Mawatari A; Ohno M; Suzuki M; Doi H; Watanabe Y; Onoe H
    J Nucl Med; 2016 Feb; 57(2):291-6. PubMed ID: 26585055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Eliminating microglia in Alzheimer's mice prevents neuronal loss without modulating amyloid-β pathology.
    Spangenberg EE; Lee RJ; Najafi AR; Rice RA; Elmore MR; Blurton-Jones M; West BL; Green KN
    Brain; 2016 Apr; 139(Pt 4):1265-81. PubMed ID: 26921617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Scavenger Receptor-A deficiency impairs immune response of microglia and astrocytes potentiating Alzheimer's disease pathophysiology.
    Cornejo F; Vruwink M; Metz C; Muñoz P; Salgado N; Poblete J; Andrés ME; Eugenín J; von Bernhardi R
    Brain Behav Immun; 2018 Mar; 69():336-350. PubMed ID: 29246456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pyroglutamate-modified amyloid-β protein demonstrates similar properties in an Alzheimer's disease familial mutant knock-in mouse and Alzheimer's disease brain.
    Wu G; Miller RA; Connolly B; Marcus J; Renger J; Savage MJ
    Neurodegener Dis; 2014; 14(2):53-66. PubMed ID: 24158021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Haplodeficiency of Cathepsin D does not affect cerebral amyloidosis and autophagy in APP/PS1 transgenic mice.
    Cheng S; Wani WY; Hottman DA; Jeong A; Cao D; LeBlanc KJ; Saftig P; Zhang J; Li L
    J Neurochem; 2017 Jul; 142(2):297-304. PubMed ID: 28429406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The blockage of the Nogo/NgR signal pathway in microglia alleviates the formation of Aβ plaques and tau phosphorylation in APP/PS1 transgenic mice.
    Fang Y; Yao L; Li C; Wang J; Wang J; Chen S; Zhou XF; Liao H
    J Neuroinflammation; 2016 Mar; 13(1):56. PubMed ID: 26939570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interferon-gamma and tumor necrosis factor-alpha regulate amyloid-beta plaque deposition and beta-secretase expression in Swedish mutant APP transgenic mice.
    Yamamoto M; Kiyota T; Horiba M; Buescher JL; Walsh SM; Gendelman HE; Ikezu T
    Am J Pathol; 2007 Feb; 170(2):680-92. PubMed ID: 17255335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Age-Dependent Sex Differences in Perineuronal Nets in an
    Rahmani R; Rambarack N; Singh J; Constanti A; Ali AB
    Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term central pathology and cognitive impairment are exacerbated in a mixed model of Alzheimer's disease and type 2 diabetes.
    Infante-Garcia C; Ramos-Rodriguez JJ; Galindo-Gonzalez L; Garcia-Alloza M
    Psychoneuroendocrinology; 2016 Mar; 65():15-25. PubMed ID: 26708068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An early dysregulation of FAK and MEK/ERK signaling pathways precedes the β-amyloid deposition in the olfactory bulb of APP/PS1 mouse model of Alzheimer's disease.
    Lachén-Montes M; González-Morales A; de Morentin XM; Pérez-Valderrama E; Ausín K; Zelaya MV; Serna A; Aso E; Ferrer I; Fernández-Irigoyen J; Santamaría E
    J Proteomics; 2016 Oct; 148():149-58. PubMed ID: 27498392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.